|
|
|
Beyond Dyslipidemia Guidelines: Is Lower Better and is Better Good Enough
Category: CME • Describe the pre-diabetes nature of the metabolic syndrome and the characteristics that identify it • Distinguish between various established and new pharmacologic agents that can be used to effectively manage dyslipidemia • Explain the clinical rationale for aggressive treatment of special populations Speaker(s): John G. McGinnity, MS, PA-C |
|
|







